Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check3 days agoChange DetectedUpdated the page revision to v3.0.2 and removed the Back to Top element. No substantive changes to core content, pricing, stock, or other critical information.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional medical topics related to cancer and genetic diseases. Notably, the previous version's specific drug information and certain location details have been removed.SummaryDifference7%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.6%
Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.